DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sai Life Sciences Limited — Investor Presentation

NSE 4 hrs ago·5 Nov 2026, 6:45 pm

SAI Life Sciences

Sai Life Sciences Limited has submitted an investor presentation to the stock exchange. This document outlines the company's current business strategy, financial performance, and future outlook for its pharmaceutical operations.

For investors, this update is significant as it provides transparency into management's plans. It helps shareholders assess the company's growth trajectory and operational efficiency in a competitive market.

Investors should monitor the presentation for specific guidance on revenue targets, margin expansion, and upcoming product launches. Keeping an eye on these details will be crucial for understanding the stock's potential.